We have written this article for those of you who feel you have been prescribed psychiatric drugs on a dubious basis for a shorter or longer period of time and fear that you are stuck and risk lifelong treatment; perhaps even with many drugs at the same time and with the feeling that none of […]
The epidemic of psychiatric drug usage – taper off the pills Read More »
The most important issue in having cancer is knowing when to say no to chemotherapy. The five pages below explains why it is prudent to decline chemotherapy for cancer most of the time it is offered. Erratum added 10 Dec 2019: ” The argument was that 5-year survival for breast cancer had risen from 12%
Chemotherapy for cancer? Surprisingly, for most cancers, it should be avoided Read More »
Landsforeningen af nuværende og tidligere psykiatribrugere interviewede Gøtzsche den 6. marts 2019 i en halv time. I videoen kommer Gøtzsche ind på de vigtigste myter i psykiatrien og forklarer, hvorfor patienterne primært har brug for psykoterapi.
LAP Interview med Peter C Gøtzsche om bl.a. neuroleptika og depressionspiller Read More »
In Norway, the Ombudsman concluded in December 2018, with reference to the Psychiatry Act, that it violated the law to use forced treatment with an antipsychotic in a concrete case. According to Norwegian law, forced drugging can only be used when, with “high probability, it can lead to recovery or significant improvement in the patient’s
Forced drugging with antipsychotics is against the law: decision in Norway Read More »
Cochrane reviews should be conducted by people that do not have financial conflicts of interest. Allowing almost half of the authors to receive financial support from the company whose product is being reviewed does not boost people’s confidence in Cochrane’s motto, “trusted evidence.” The Cochrane review of the HPV vaccines from May 2018 is illustrative.
Cochrane authors on drug industry payroll should not be allowed, abstract Read More »
Gøtzsche, comments on Statement by Cochrane Governing Board from 17 Sept
Gøtzsche, comments on Statement by Cochrane Governing Board from 17 Sept Read More »
Brug af depressionspiller til børn næsten halveret
Forbruget af depressionspiller er næsten halveret hos børn og unge i Danmark Read More »
En statusartikel i Ugeskrift for Læger om overdødelighed ved skizofreni [1] hævder, at neuroleptika i korterevarende forsøg reducerer dødsrisikoen [2], og at dette underbygges af længerevarende observationelle studier [3]. Neuroleptika er meget toksiske, og de reducerer ikke dødelighen; de øger den [4]. De to artikler, der citeres i statusartiklen, er upålidelige, hvilket jeg har forklaret
Neuroleptika øger dødeligheden Read More »
I professor, dr.med. Lars Vedel Kessings afsnit i Patienthåndbogen, ”Depression, hvordan virker medicin”, forekommer fortsat åbenlyse fejl og meget misvisende oplysninger, som for nogles vedkommende er direkte skadelige for patienterne. De bør rettes uden unødig forsinkelse. Efter mit brev fra til redaktionen fra 3. februar har Kessing ændret i dette afsnit 6. februar 2017, men
Af alle tyrannier er det tyranni, som oprigtigt udøves for at gavne ofrene, det mest undertrykkende. Det ville være bedre at leve under røverbaroner end under almægtige moralske plageånder. Røverbaronens grusomhed sover undertiden, og hans begærlighed mættes på et tidspunkt; men de, der piner os for vores eget bedste, vil pine os uden ophør, fordi
Tvangsindlæggelse og tvangsbehandling bør forbydes Read More »